The GCI Dream team: over 80 professionals in offices in NY, LA, San Francisco, Atlanta, Chicago, Toronto and the U.K., agency veterans, former corporate executives and some of the brightest up and coming professionals in the business.
Meet our leadership team.
Wendy Lund
CEO
Wendy joined GCI Health as CEO in early 2010 and oversees all operations across the agency's global network. She is acutely aware that the healthcare industry is entering a decade of transformation and shares a deep passion with her entire team for helping clients manage the challenges that lie ahead. Throughout her 25 years of experience, Wendy has led pre-approval and launch programs for a variety of high profile drugs and medical devices and has led award-winning national and globally recognized programs in marketing, advocacy development, health and disease awareness and prevention outreach. She also has deep experience in healthcare crisis communications and has counseled senior executives from corporations, not-for-profits and advocacy groups on reputation management, stakeholder relations, executive leadership and corporate responsibility. The first 13 years of her career were spent as a healthcare advocate during which time she served as vice president at Planned Parenthood Federation of America and as vice president at the National League for Nursing.
Jill Dosik
President
If you ask Jill, a 16-year veteran of GCI Health, about the emerging trends facing the healthcare industry you will see what it means to truly know your subject matter and how to communicate it with contagious energy and simplicity. A member of the New York State Bar, Jill brings sharp analytical skills to challenges in the oncology, biotechnology, psychiatric, cardiovascular, and CNS arenas and also excels at communicating technical, high-science and esoteric information in ways that resonate with a variety of audiences. She has led pre and post-approval strategies for such clients as Genentech, ImClone, and Sanofi-Aventis, has reintroduced old drugs with new uses, has led campaigns to protect blockbuster brands and has provided crisis management counsel to companies in the national spotlight. She currently provides strategic counsel for Biogen Idec's MS drug Tysabri and pipeline products.
Mark Davis
SVP, Digital
Mark joined GCI Health as the Director of Digital Health in October 2010 to sustain and build the strategic vision for the agency’s digital health offering, further integrate digital solutions and develop and enhance products and services. Mark was most recently at Novartis Pharmaceuticals where he was the Director of Social Media. In this role, he developed key organizational capabilities for social media, including regulatory and legal standard operating procedures, as well as a strategic brand opportunity framework which guided social media prioritization and development across all brands. Earlier in his career at Novartis, Mark was a Director in the Integrated Marketing Solutions Group where he championed an integrated, multi-channel approach that leveraged digital promotion and Web 2.0 technologies for several specialty brands. Prior to Novartis, Mark was at Merck-Medco (now Medco) where as Vice President, Consumer Experience, he led the team which developed digital messaging strategies to increase proper prescription treatment and adherence for several key therapeutic areas.
Jim Wetmore
Market Leader, West Coast
Before heading the West Coast offices of GCI Health, Jim spent two years in the New York office and today embodies the kind of professional capable of making an impact no matter where he sits. His clients gravitate to his no-nonsense counsel and his teams are motivated to exceed his expectations. For the past 12 years, Jim has focused on strategic market development, issues management, advocacy relations and corporate change communications for leading biotech, pharmaceutical and non-profit clients. He is currently providing strategic counsel for Biogen Idec's Tysabri and multiple sclerosis pipeline. Jim supported U.S. activities for Lucentis, Genentech's therapy for wet-age related macular degeneration, Flomax, Boehringer Ingelheim's treatment for benign prostatic hyperplasia (BPH), and Zyprexa, Eli Lilly and Company's antipsychotic for the treatment of schizophrenia and bipolar disorder. Jim also helped lead U.S. and global internal corporate change initiatives at Johnson & Johnson and Merck.
Valerie Lind
Market Leader, Atlanta
Valerie brings the valuable perspective of being a client during the early part of her healthcare communications career having led the global media relations and public awareness programs for Medtronic, Inc.'s Cardiac Rhythm Disease Management business. It has enabled her to consistently and effectively align communications strategies with business objectives while never losing sight of the need to stay fearless about innovating. As the head of the GCI Health Atlanta office she leads her team to do the same. Valerie has extensive experience in disease awareness, product communications and therapy access campaigns; corporate reputation; data and regulatory milestone communications; and employee change management programs. She currently leads programs from Endo Pharmaceuticals, Johnson & Johnson, and Medtronic.
Kristin Cahill
EVP, New York, Market Leader
Kristin personifies what it means to fearlessly tackle a challenge and drive success on behalf of her clients. She has worked with a wide range of pharmaceutical, biotechnology, medical device, health information technology and non-profit clients with a particular focus on complex treatments and patient populations. She has extensive experience managing product launches, including Genentech's Lucentis, a breakthrough treatment for wet age-related macular degeneration, Boehringer Ingelheim's Aptivus, a protease inhibitor for treatment-resistant HIV patients and most recently, Allergan's Botox for Chronic Migraine. Kristin also has extensive stakeholder relations experience and spent several years managing advocacy relations and issues management for Boehringer Ingelheim's HIV franchise and Merck's pediatric vaccine portfolio. Kristin has also helped build GCI Health's digital media capabilities and worked with multiple healthcare companies to develop social media guidelines and product-specific strategies.